A Quote, Financials, Valuation and Earnings

Azenta has a net margin of 12.89% compared to Agilent Technologies's net margin of -28.21%. Agilent Technologies's return on equity of 19.32% beat Azenta's return on equity of -3.48%.

Agilent Technologies has a consensus price target of $136.83, signalling upside risk potential of 16.87%. On the other hand Azenta has an analysts' consensus of $41.60 which suggests that it could grow by 35.95%. Given that Azenta has higher upside potential than Agilent Technologies, analysts believe Azenta is more attractive than Agilent Technologies.

Agilent Technologies has a beta of 1.229, which suggesting that the stock is 22.903% more volatile than S&P 500. In comparison Azenta has a beta of 1.616, suggesting its more volatile than the S&P 500 by 61.626%.

Agilent Technologies has a quarterly dividend of $0.25 per share corresponding to a yield of 0.83%. Azenta offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Agilent Technologies pays 21.26% of its earnings as a dividend. Azenta pays out -- of its earnings as a dividend. Agilent Technologies's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Agilent Technologies quarterly revenues are $1.7B, which are larger than Azenta quarterly revenues of $143.4M. Agilent Technologies's net income of $215M is higher than Azenta's net income of -$40.5M. Notably, Agilent Technologies's price-to-earnings ratio is 28.91x while Azenta's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Agilent Technologies is 5.07x versus 2.32x for Azenta. Usually stocks with elevated PS ratios are considered overvalued.

Bruker has a net margin of 12.89% compared to Agilent Technologies's net margin of 2.17%. Agilent Technologies's return on equity of 19.32% beat Bruker's return on equity of 4.53%.

Agilent Technologies has a consensus price target of $136.83, signalling upside risk potential of 16.87%. On the other hand Bruker has an analysts' consensus of $55.97 which suggests that it could grow by 46.15%. Given that Bruker has higher upside potential than Agilent Technologies, analysts believe Bruker is more attractive than Agilent Technologies.

Agilent Technologies has a beta of 1.229, which suggesting that the stock is 22.903% more volatile than S&P 500. In comparison Bruker has a beta of 1.156, suggesting its more volatile than the S&P 500 by 15.599%.

Agilent Technologies has a quarterly dividend of $0.25 per share corresponding to a yield of 0.83%. Bruker offers a yield of 0.52% to investors and pays a quarterly dividend of $0.05 per share. Agilent Technologies pays 21.26% of its earnings as a dividend. Bruker pays out 26.7% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Agilent Technologies quarterly revenues are $1.7B, which are larger than Bruker quarterly revenues of $801.4M. Agilent Technologies's net income of $215M is higher than Bruker's net income of $17.4M. Notably, Agilent Technologies's price-to-earnings ratio is 28.91x while Bruker's PE ratio is 73.65x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Agilent Technologies is 5.07x versus 1.68x for Bruker. Usually stocks with elevated PS ratios are considered overvalued.

Harvard Bioscience has a net margin of 12.89% compared to Agilent Technologies's net margin of -231.19%. Agilent Technologies's return on equity of 19.32% beat Harvard Bioscience's return on equity of -103.83%.

Agilent Technologies has a consensus price target of $136.83, signalling upside risk potential of 16.87%. On the other hand Harvard Bioscience has an analysts' consensus of $3.00 which suggests that it could grow by 489.62%. Given that Harvard Bioscience has higher upside potential than Agilent Technologies, analysts believe Harvard Bioscience is more attractive than Agilent Technologies.

Agilent Technologies has a beta of 1.229, which suggesting that the stock is 22.903% more volatile than S&P 500. In comparison Harvard Bioscience has a beta of 1.559, suggesting its more volatile than the S&P 500 by 55.863%.

Agilent Technologies has a quarterly dividend of $0.25 per share corresponding to a yield of 0.83%. Harvard Bioscience offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Agilent Technologies pays 21.26% of its earnings as a dividend. Harvard Bioscience pays out -- of its earnings as a dividend. Agilent Technologies's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Agilent Technologies quarterly revenues are $1.7B, which are larger than Harvard Bioscience quarterly revenues of $21.8M. Agilent Technologies's net income of $215M is higher than Harvard Bioscience's net income of -$50.3M. Notably, Agilent Technologies's price-to-earnings ratio is 28.91x while Harvard Bioscience's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Agilent Technologies is 5.07x versus 0.24x for Harvard Bioscience. Usually stocks with elevated PS ratios are considered overvalued.

Revvity has a net margin of 12.89% compared to Agilent Technologies's net margin of 6.35%. Agilent Technologies's return on equity of 19.32% beat Revvity's return on equity of 3.68%.

Agilent Technologies has a consensus price target of $136.83, signalling upside risk potential of 16.87%. On the other hand Revvity has an analysts' consensus of $124.83 which suggests that it could grow by 33.47%. Given that Revvity has higher upside potential than Agilent Technologies, analysts believe Revvity is more attractive than Agilent Technologies.

Agilent Technologies has a beta of 1.229, which suggesting that the stock is 22.903% more volatile than S&P 500. In comparison Revvity has a beta of 0.967, suggesting its less volatile than the S&P 500 by 3.35%.

Agilent Technologies has a quarterly dividend of $0.25 per share corresponding to a yield of 0.83%. Revvity offers a yield of 0.3% to investors and pays a quarterly dividend of $0.07 per share. Agilent Technologies pays 21.26% of its earnings as a dividend. Revvity pays out 12.74% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Agilent Technologies quarterly revenues are $1.7B, which are larger than Revvity quarterly revenues of $664.8M. Agilent Technologies's net income of $215M is higher than Revvity's net income of $42.2M. Notably, Agilent Technologies's price-to-earnings ratio is 28.91x while Revvity's PE ratio is 39.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Agilent Technologies is 5.07x versus 4.12x for Revvity. Usually stocks with elevated PS ratios are considered overvalued.